Prevalence of Systolic and Diastolic Dysfunction in Patients with Type 1 Diabetes Without Known Heart Disease: the Thousand & 1 Study
Overview
Authors
Affiliations
Aims/hypothesis: Heart failure is one of the leading causes of mortality in type 1 diabetes. Early identification is vitally important. We sought to determine the prevalence and clinical characteristics associated with subclinical impaired systolic and diastolic function in type 1 diabetes patients without known heart disease.
Methods: In this cross-sectional examination of 1,093 type 1 diabetes patients without known heart disease, randomly selected from the Steno Diabetes Center, complete clinical and echocardiographic examinations were performed and analysed in uni- and multivariable regression models.
Results: The mean (SD) age was 49.6 (15) years, 53% of participants were men, and the mean duration of diabetes was 25.5 (15) years. Overall, 15.5% (n = 169) of participants had grossly abnormal systolic or diastolic function, including 1.7% with left ventricular ejection fraction (LVEF) < 45% and 14.4% with evidence of long-standing diastolic dysfunction. In univariable models, clinical characteristics associated with abnormal myocardial function were: age (per 10 years), OR (95% CI) 2.1 (1.8, 2.4); diabetes duration (per 10 years), 1.7 (1.4, 1.9); systolic BP ≥ 140 mmHg, 2.7 (1.9, 3.8); diastolic BP ≥ 90 mmHg, 1.8 (1.0, 3.1); estimated (e)GFR < 60 ml min(-1) 1.73 m(-2), 3.8 (2.5, 5.9); microalbuminuria, 2.0 (1.3, 3.0); macroalbuminuria, 5.9 (3.8, 9.3); proliferative retinopathy, 3.6 (2.3, 5.8); blindness, 10.1 (3.2, 31.6); and peripheral neuropathy, 3.8 (2.7, 5.3). In multivariable models only age (2.1 [1.7, 2.5]), female sex, (1.9 [1.2, 2.8]) and macroalbuminuria (5.2 [2.9, 10.3]) remained significantly associated with subclinical grossly abnormal myocardial function.
Conclusions/interpretation: Subclinical myocardial dysfunction is a common finding in type 1 diabetes patients without known heart disease. Type 1 diabetes patients with albuminuria are at greatly increased risk of having subclinical abnormal myocardial function compared with patients without albuminuria. Echocardiography may be particularly warranted in patients with albuminuria.
Brodersen B, Kristiansen L, le Fevre Karlsen S, Hauch J, Andreasen J, Kragholm K Clin Res Cardiol. 2025; .
PMID: 39992384 DOI: 10.1007/s00392-025-02594-8.
Prevalence of Cardiomyopathy in Patients with Type 1 Diabetes Mellitus.
Fabila-de la Cruz O, Luna-Avila E, Sotelo-Gonzalez M, Litardo-Mosquera A, Orihuela O, Ferreira-Hermosillo A J Clin Med. 2024; 13(18).
PMID: 39336838 PMC: 11432088. DOI: 10.3390/jcm13185351.
The role of aetiology in cardiac manifestations of chronic kidney disease: the CPH-CKD ECHO study.
Christensen J, Landler N, Olsen F, Sorensen I, Bjergfelt S, Ballegaard E Int J Cardiovasc Imaging. 2024; 40(6):1221-1233.
PMID: 38687429 PMC: 11213755. DOI: 10.1007/s10554-024-03092-0.
The double burden: type 1 diabetes and heart failure-a comprehensive review.
Julian M, Perez-Montes de Oca A, Julve J, Alonso N Cardiovasc Diabetol. 2024; 23(1):65.
PMID: 38347569 PMC: 10863220. DOI: 10.1186/s12933-024-02136-y.
Female is Associated with Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
Wang Y, Zhou Y, Zhang Y, Ren Q, Wang Y, Su H Diabetes Metab Syndr Obes. 2023; 16:2355-2364.
PMID: 37577043 PMC: 10416790. DOI: 10.2147/DMSO.S421761.